October 19th is Max’s Day
October 19th is Max’s Day. We honor the day because it marks Max’s birthday. At the very same time, we honor all the people who have been helped in his name.
March 9th marks a somber anniversary; the day Max lost his 3 year battle with chronic myeloid leukemia (CML). For those of us who love Max, who either knew him then or who know and love him now, this will always be a day of sorrow. The words that come to mind are words such as ugly, unfair, impossible, and the feeling is one of emptiness; a whole in one’s heart. Max was a real person, a beautiful young child, whose encounter with cancer was nothing but a tragic episode.
Yes, we do so much in his memory; his spirit lives through those who are alive today, and I personally have found a calling I never would have envisioned. But don’t get me wrong; I would give it all up in a heartbeat to have Max back, to have taken away his pain and to see him today.
We do what we do every day because we can, and words cannot describe our gratitude for the opportunity. We have indeed built a magnificent global movement in his honor, and our commitment to access to treatment, care and support, and our vision or dignity and hope in the face of cancer is stronger than ever. But as anyone who has lost a young dear one knows, the hole in the heart remains. We acknowledge it and accept that it will always be there, and we learn to live with it.
And today, we pause to light a candle and say a prayer. I would like to invite you to light a candle today, for Max and for all the friends and loved ones who are no longer with us. Let’s be together through the power of social media by leaving a message in the guestbook, sharing our love for each other and let our togetherness be a reminder that cancer didn’t win. It made us stronger and more determined, for Max and for all those who are no longer with us.
Thank you,
Pat Garcia-Gonzalez

Pat Garcia-Gonzalez is the CEO of The Max Foundation. Under Pat’s direction The Max Foundation is dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses, focusing our energy on those who no one else is helping. Pat lives in Edmonds, Washington, where she raised her four sons.

Thousands of patients are diagnosed with chronic myeloid leukaemia (CML) annually around the world. CML, like any other cancer, does not discriminate. It affects people from all regions and walks of life. However, unlike many other cancers, CML has an amazing story due to advancements made in its treatment in the last decade. It was only 15 years ago that a patient newly diagnosed with CML would have a prognosis of survival of less than 5 years with the treatments available at the time.

Dr. Jayasree Iyer, Executive Director of the Access to Medicine Foundation (ATMF), sits down with The Max Foundation and answers seven questions about the Access to Medicine Index, emerging trends in treatment access, and the role of collaborative access initiatives in treating chronic diseases.